Literature DB >> 19041901

Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking.

Wayne E Pratt1, Kaitlin Blackstone.   

Abstract

Separate groups of food-deprived rats were given 2h access to food after receiving bilateral nucleus accumbens infusions of the muscarinic antagonist scopolamine methyl bromide (at 0, 1.0, and 10.0 microg/side), the M2-preferring agonist oxotremorine sesquifumarate (Oxo-S; at 0, 1.0, or 10.0 microg/side) or the M2 antagonist AFDX-116 (at 0, 0.2, or 1.0 microg/side). Injections of scopolamine or Oxo-S, but not AFDX-116, reduced food consumption across the 2h. These experiments confirm a critical role for Acb acetylcholine in promoting food ingestion, and suggest that decreased acetylcholine tone at post-synaptic muscarinic receptors disrupts normal consummatory behavior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041901     DOI: 10.1016/j.bbr.2008.11.008

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  12 in total

1.  A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.

Authors:  Wayne E Pratt; Kara A Clissold; Peagan Lin; Amanda E Cain; Alexa F Ciesinski; Thomas R Hopkins; Adeolu O Ilesanmi; Erin A Kelly; Zachary Pierce-Messick; Daniel S Powell; Ian A Rosner
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

2.  Serotonin 1A, 1B, and 7 receptors of the rat medial nucleus accumbens differentially regulate feeding, water intake, and locomotor activity.

Authors:  Kara A Clissold; Eugene Choi; Wayne E Pratt
Journal:  Pharmacol Biochem Behav       Date:  2013-10-11       Impact factor: 3.533

Review 3.  Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa.

Authors:  Nicole M Avena; Miriam E Bocarsly
Journal:  Neuropharmacology       Date:  2011-11-27       Impact factor: 5.250

4.  Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost-benefit decision making tasks in rats.

Authors:  Ian A Mendez; Ryan J Gilbert; Jennifer L Bizon; Barry Setlow
Journal:  Psychopharmacology (Berl)       Date:  2012-07-04       Impact factor: 4.530

5.  Contrasting effects of 5-HT3 receptor stimulation of the nucleus accumbens or ventral tegmentum on food intake in the rat.

Authors:  Wayne E Pratt; Peagan Lin; Zachary Pierce-Messick; Adeolu O Ilesanmi; Kara A Clissold
Journal:  Behav Brain Res       Date:  2017-01-20       Impact factor: 3.332

6.  Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.

Authors:  Pedro Rada; Jessica R Barson; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

7.  Overlapping striatal sites mediate scopolamine-induced feeding suppression and mu-opioid-mediated hyperphagia in the rat.

Authors:  Michelle L Perry; Wayne E Pratt; Brian A Baldo
Journal:  Psychopharmacology (Berl)       Date:  2013-11-05       Impact factor: 4.530

8.  The effects of nucleus accumbens μ-opioid and adenosine 2A receptor stimulation and blockade on instrumental learning.

Authors:  Kara A Clissold; Wayne E Pratt
Journal:  Behav Brain Res       Date:  2014-08-04       Impact factor: 3.332

Review 9.  Principles of motivation revealed by the diverse functions of neuropharmacological and neuroanatomical substrates underlying feeding behavior.

Authors:  Brian A Baldo; Wayne E Pratt; Matthew J Will; Erin C Hanlon; Vaishali P Bakshi; Martine Cador
Journal:  Neurosci Biobehav Rev       Date:  2013-03-01       Impact factor: 8.989

10.  Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression.

Authors:  Karolina P Skibicka; Caroline Hansson; Emil Egecioglu; Suzanne L Dickson
Journal:  Addict Biol       Date:  2011-02-11       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.